Nektar Therapeutics | NKTR - Rentabilidad Por Dividendo





Dy Cambio Fecha
Alterity Therapeutics Limited AUD 0 0 2024-12
Amgen 2.71 0.08 2026-06
Baxter International 0.14 2 2026-06
BioCryst Pharmaceuticals 0 0 2025-03
Bristol-Myers Squibb 4.36 0.23 2026-06
Cara Therapeutics 0 0 2025-03
Cipla 0.89 0.18 2026-06
Dr.Reddys Laboratories 0.59 0.05 2026-06
Eisai 3.88 0.6 2026-06
Eli Lilly 0.56 0.02 2026-06
Gilead Sciences 2.55 0.26 2026-06
GlaxoSmithKline 0.86 0.03 2026-06
Grifols EUR 1.88 0.68 2025-12
Karyopharm Therapeutics 0 0 2025-03
Merck 2.62 0.14 2026-06
Nektar Therapeutics 0 0 2025-03
Novartis USD 3.1 0.23 2026-06
Pfizer 7.08 0.72 2026-06
Roche Holding 2.94 0.01 2026-06
Takeda 3.88 2.23 2026-06